2007 Pharma Safety 
Pharmaceutical Technology
FEBRUARY 24, 2023
The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. You can compare timelines.
pharmaphorum
NOVEMBER 30, 2022
Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 22, 2023
According to the information sharing platform AMR Insights , AMR is considered one of the biggest global threats to health and food safety. Soulsby and Brooks explain what the new certification means for antibiotic manufacturers and the wider pharma industry, and its anticipated benefit for supply chain sustainability.
Pharmaceutical Technology
OCTOBER 13, 2022
Colonis Pharma is a subsidiary company within Clinigen. However, the UK’s Electronic Medicines Compendium (EMC) states that “the safety and efficacy of Circadin in children aged 0 to 18 years has not yet been established.” The therapeutic is meant for youth with ADHD aged 6-17 years who found sleep hygiene measures inadequate.
Pharmaceutical Technology
OCTOBER 5, 2008
But the recent acquisition by Japanese pharmaceutical provider Shionogi of US-based rival Sciele Pharma, worth $1,276m, is just the latest in a spree of big and bold outbound deals. “Ranbaxy led the way with eight acquisitions and is aspiring to be a $2bn company by 2007.” % increase over the previous year.
European Pharmaceutical Review
DECEMBER 12, 2023
Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. As a biotech, what work does Innate Pharma do in the biopharma industry? Can you describe Innate Pharma’s clinical stage pipeline?
Pharmaceutical Technology
AUGUST 26, 2008
However, a wave of exciting monoclonal antibody products was being developed, and these were quickly partnered with big pharma which demonstrated the increasing commercial opportunity for biotechnology. “There have been doubts about the extent to which the high prices paid by big pharmaceuticals were justified in the short term.”
Expert insights. Personalized for you.
64 
Let's personalize your content